schizandrin b has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, K; Ge, J; Gong, S; Li, J; Li, X; Ma, L; Song, T; Zhang, J; Zhao, Y; Zheng, Y | 1 |
| Cheng, L; Fei, L; Han, X; Nie, S; Pan, H; Ren, Y; Sun, Z; Wang, M; Xie, J; Yang, Z; Zhang, W; Zhao, Y | 1 |
2 other study(ies) available for schizandrin b and Chemical and Drug Induced Liver Injury, Chronic
| Article | Year |
|---|---|
Schisandrin B ameliorates acute liver injury by regulating EGFR-mediated activation of autophagy.
Topics: Acetaminophen; Autophagy; Chemical and Drug Induced Liver Injury, Chronic; ErbB Receptors; Humans; Molecular Docking Simulation | 2023 |
Schizandrin B Mitigates Rifampicin-Induced Liver Injury by Inhibiting Endoplasmic Reticulum Stress.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury, Chronic; Cyclooctanes; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Hepatocytes; Humans; Lignans; Polycyclic Compounds; Protective Agents; Schisandra | 2020 |